Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$12.44 - $17.48 $1.64 Million - $2.3 Million
-131,573 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$14.51 - $19.71 $783,540 - $1.06 Million
54,000 Added 69.61%
131,573 $2.19 Million
Q1 2019

May 10, 2019

BUY
$11.11 - $25.6 $123,443 - $284,441
11,111 Added 16.72%
77,573 $1.36 Million
Q4 2018

Jan 31, 2019

BUY
$11.75 - $21.42 $258,500 - $471,240
22,000 Added 49.48%
66,462 $837,000
Q3 2018

Nov 09, 2018

BUY
$19.26 - $23.46 $856,338 - $1.04 Million
44,462 New
44,462 $951,000

Others Institutions Holding MGNX

About MACROGENICS INC


  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $146M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Fosun International LTD Portfolio

Follow Fosun International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fosun International LTD with notifications on news.